Xeris Biopharma Holdings Inc. buy SVB Leerink LLC
Start price
10.03.25
/
50%
€4.21
Target price
10.03.26
€5.52
Performance (%)
42.06%
Price
11.12.25
€5.98
Summary
This prediction is currently active. The BUY prediction by SVB_Leerink_LLC for Xeris Biopharma Holdings Inc. has seen massive gains of 42.06%. This prediction currently runs until 10.03.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Xeris Biopharma Holdings Inc. | 3.463% | 3.463% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) had its price target raised by analysts at Leerink Partners from $5.00 to $6.00. They now have an "outperform" rating on the stock.
Ratings data for XERS provided by MarketBeat
Stopped prediction by SVB_Leerink_LLC for Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€6.61
22.08.25
22.08.25
€7.75
22.08.26
22.08.26
-9.61%
11.12.25
11.12.25
